Showing results (451-460 of 546) with videos related to
Sort By:
Pageof 55
ESMO Open|April 19, 2023
Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registryK Riecke, V Müller, T Neunhöffer, et al.Geburtshilfe Und Frauenheilkunde|November 11, 2020
Update Breast Cancer 2020 Part 3 - Early Breast CancerJens Huober, Andreas Schneeweiss, Andreas D Hartkopf, et al.Geburtshilfe Und Frauenheilkunde|August 24, 2023
Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer - Controversies and Standards in HealthcareVolkmar Müller, Peter A Fasching, Naiba Nabieva, et al.Geburtshilfe Und Frauenheilkunde|August 4, 2017
Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)Michael Untch, Jens Huober, Christian Jackisch, et al.Annals of Hematology|April 14, 2023
Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort studyJuliette Pénichoux, Hélène Lanic, Caroline Thill, et al.Journal of Cancer Research and Clinical Oncology|June 19, 2025
The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA studyAndreas Schneeweiss, Peter A Fasching, Marc Thill, et al.JAMA Oncology|May 19, 2022
Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer: The GeparX 2 × 2 Randomized Clinical TrialJens-Uwe Blohmer, Theresa Link, Mattea Reinisch, et al.Science (New York, N.Y.)|July 5, 2014
Molecular kinetics. Ras activation by SOS: allosteric regulation by altered fluctuation dynamicsLars Iversen, Hsiung-Lin Tu, Wan-Chen Lin, et al.Frontiers in Oncology|February 28, 2022
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast CancerAlberto Ocaña, Jose Ignacio Chacón, Lourdes Calvo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX TrialTheresa Link, Jens-Uwe Blohmer, Wolfgang D Schmitt, et al.Pageof 55